No black box warning on record for Zoladex

As of the latest FDA labeling reviewed, Zoladex (GOSERELIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Zoladex medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Women of Childbearing Potential and Pregnancy: Pregnancy must be excluded for use in benign gynecological conditions. Women should avoid pregnancy ( 5.1 ) Tumor Flare Phenomenon: Transient worsening of tumor symptoms may occur during the first few weeks of treatment with ZOLADEX, which may include ureteral obstruction and spinal cord compression. Monitor patients at risk

No black box warning on record for Zoladex

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Women of Childbearing Potential and Pregnancy: Pregnancy must be excluded for use in benign gynecological conditions. Women should avoid pregnancy ( 5.1 ) Tumor Flare Phenomenon: Transient worsening of tumor symptoms may occur during the first few weeks of treatment with ZOLADEX, which may include ureteral obstruction and spinal cord compression. Monitor patients at risk

Zoladex Black Box Warning

No black box warning on record for Zoladex

Other warnings & precautions

Zoladex Black Box Warning

No black box warning on record for Zoladex

Other warnings & precautions